These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38135816)

  • 21. MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.
    Ivanidze J; Lum M; Pisapia D; Magge R; Ramakrishna R; Kovanlikaya I; Fine HA; Chiang GC
    J Neuroimaging; 2019 May; 29(3):357-363. PubMed ID: 30644143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.
    Armocida D; Frati A; Salvati M; Santoro A; Pesce A
    Clin Neurol Neurosurg; 2020 Nov; 198():106126. PubMed ID: 32861131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging findings of intracranial extraventricular ependymoma: A retrospective multi-center cohort study of 114 cases.
    Li L; Fu Y; Zhang Y; Mao Y; Huang D; Yi X; Wang J; Tan Z; Jiang M; Chen BT
    Cancer Med; 2023 Aug; 12(15):16195-16206. PubMed ID: 37376821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma.
    Rao A; Rao G; Gutman DA; Flanders AE; Hwang SN; Rubin DL; Colen RR; Zinn PO; Jain R; Wintermark M; Kirby JS; Jaffe CC; Freymann J;
    J Neurosurg; 2016 Apr; 124(4):1008-17. PubMed ID: 26473782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach.
    Cao M; Suo S; Zhang X; Wang X; Xu J; Yang W; Zhou Y
    Biomed Res Int; 2021; 2021():1235314. PubMed ID: 33553421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric Magnetic Resonance Imaging Correlates of Isocitrate Dehydrogenase Mutation in WHO high-Grade Astrocytomas.
    Sahu A; Patnam NG; Goda JS; Epari S; Sahay A; Mathew R; Choudhari AK; Desai SM; Dasgupta A; Chatterjee A; Pratishad P; Shetty P; Moiyadi AA; Gupta T
    J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas.
    Lu J; Li X; Li H
    Magn Reson Imaging; 2021 Nov; 83():189-195. PubMed ID: 34506909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
    Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
    Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of
    Park YW; Han K; Ahn SS; Bae S; Choi YS; Chang JH; Kim SH; Kang SG; Lee SK
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):37-42. PubMed ID: 29122763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic Contrast-Enhanced T1-Weighted Perfusion Magnetic Resonance Imaging Identifies Glioblastoma Immunohistochemical Biomarkers via Tumoral and Peritumoral Approach: A Pilot Study.
    Ozturk K; Soylu E; Tolunay S; Narter S; Hakyemez B
    World Neurosurg; 2019 Aug; 128():e195-e208. PubMed ID: 31003026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma.
    Wang J; Yi X; Fu Y; Pang P; Deng H; Tang H; Han Z; Li H; Nie J; Gong G; Hu Z; Tan Z; Chen BT
    Front Oncol; 2021; 11():769188. PubMed ID: 34778086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
    Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
    Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical evaluation of cystic features in patients with newly diagnosed glioblastoma with IDH-wildtype.
    Kim MJ; Park JS; Jeun SS; Ahn S
    Clin Neurol Neurosurg; 2023 May; 228():107708. PubMed ID: 37043844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative susceptibility mapping evaluation of glioma.
    Zeng S; Ma H; Xie D; Huang Y; Wang M; Zeng W; Zhu N; Ma Z; Yang Z; Chu J; Zhao J
    Eur Radiol; 2023 Oct; 33(10):6636-6647. PubMed ID: 37095360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma.
    Verduin M; Primakov S; Compter I; Woodruff HC; van Kuijk SMJ; Ramaekers BLT; te Dorsthorst M; Revenich EGM; ter Laan M; Pegge SAH; Meijer FJA; Beckervordersandforth J; Speel EJ; Kusters B; de Leng WWJ; Anten MM; Broen MPG; Ackermans L; Schijns OEMG; Teernstra O; Hovinga K; Vooijs MA; Tjan-Heijnen VCG; Eekers DBP; Postma AA; Lambin P; Hoeben A
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional MRI features can predict the molecular subtype of adult grade 2-3 intracranial diffuse gliomas.
    Lasocki A; Buckland ME; Drummond KJ; Wei H; Xie J; Christie M; Neal A; Gaillard F
    Neuroradiology; 2022 Dec; 64(12):2295-2305. PubMed ID: 35606654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma.
    Du N; Shu W; Li K; Deng Y; Xu X; Ye Y; Tang F; Mao R; Lin G; Li S; Fang X
    J Transl Med; 2023 Feb; 21(1):119. PubMed ID: 36774480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular architecture mapping for early detection of glioblastoma recurrence.
    Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
    Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
    Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
    Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined texture analysis of dynamic contrast-enhanced MRI with histogram analysis of diffusion kurtosis imaging for predicting IDH mutational status in gliomas.
    Pan T; Su CQ; Tang WT; Lin J; Lu SS; Hong XN
    Acta Radiol; 2023 Sep; 64(9):2552-2560. PubMed ID: 37331987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.